Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 672-683
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.672
Table 4 Comparison of key outcomes between participating hospitals

Site 1 (n = 254)
Site 2 (n = 396)
Site 3 (n = 604)
Site 4 (n = 790)
Site 5 (n = 399)
P value
Overall (n = 2443)
Patient age, median (IQR)56 (46-66)61 (50-71)59.5 (49-70)61 (50-71)60 (50-71)< 0.00160 (50-70)
Patient gender (male %)56.7 (n = 144)45.7 (n = 181)48.0 (n = 290)48.4 (n = 382)50.4 (n = 201)0.0849.0 (n = 1197)
Proceduralist
Surgical (%)87.4 (n = 222)33.1 (n = 131)35.6 (n = 215)35.9 (n = 284)51.4 (n = 205)< 0.00143.3 (n = 1057)
Medical (%)12.6 (n = 32)66.9 (n = 265)64.1 (n = 387)50.5 (n = 399)48.4 (n = 193)< 0.00152.2 (n = 1276)
Trainee (%)59.4 (n = 151)38.9 (n = 154)8.1 (n = 49)28.1 (n = 222)38.1 (n = 152)< 0.00129.8 (n = 728)
Medical (%)0 (n = 0)61.7 (n = 95)91.8 (n = 45)39.2 (n = 87)70.4 (n = 107)-45.9 (n = 334)
Surgical (%)100 (n = 151)38.3 (n = 59)8.2 (n = 4)60.8 (n = 135)29.6 (n = 45)-54.1 (n = 394)
Inadequate bowel preparation (%)13.4 (n = 34)8.1 (n = 32)2.6 (n = 16)7.2 (n = 57)9.8 (n = 39)< 0.0017.3 (n = 178)
Indeterminate bowel preparation (%)0.0 (n = 0)2.8 (n = 11)1.5 (n = 9)4.3 (n = 34)22.1 (n = 88)< 0.0015.8 (n = 142)
Procedure completion (%)94.3 (n = 215)92.2 (n = 319)98.2 (n = 556)95.1 (n = 686)93.4 (n = 338)< 0.00195.1 (n = 2114)
Procedure completion (%) with adequate preparation98.0 (n = 195)94.5 (n = 294)99.2 (n = 537)98.0 (n = 627)96.3 (n = 233)0.9997.5 (n = 1886)
Eligible procedures1212163814621601340
Cancer detection (%)5.0 (n = 6)2.3 (n = 5)2.9 (n = 11)3.5 (n = 16)5.6 (n = 9)0.383.5 (n = 47)
CSPDR (%)30.4 (n = 35)40.8 (n = 86)48.6 (n = 180)42.6 (n = 190)41.1 (n = 62)0.0142.8 (n = 553)
ADR (%)27.8 (n = 32)39.3 (n = 83)45.7 (n = 169)39.5 (n = 176)37.7 (n = 57)0.0140.0 (n = 517)
SLDR (%)2.6 (n = 3)5.2 (n = 11)5.1 (n = 19)7.4 (n = 33)6.6 (n = 10)0.315.9 (n = 76)